NASDAQ:BNR Burning Rock Biotech (BNR) Stock Price, News & Analysis $11.82 -1.43 (-10.79%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$12.30 +0.48 (+4.06%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Burning Rock Biotech Stock (NASDAQ:BNR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Burning Rock Biotech alerts:Sign Up Key Stats Today's Range$11.60▼$13.5150-Day Range$9.22▼$18.9452-Week Range$6.79▼$41.72Volume51,636 shsAverage Volume29,969 shsMarket Capitalization$124.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Burning Rock Biotech Limited is a biotechnology company focused on precision oncology. The company develops and commercializes next-generation sequencing (NGS) tests designed to help detect cancer, guide treatment decisions and monitor patients during therapy. Its offerings include tissue- and blood-based genomic testing for cancer patients, as well as tests intended to support therapy selection, treatment monitoring and the identification of biomarkers relevant to targeted medicines and immunotherapies. Burning Rock also develops early cancer-detection technologies, including liquid-biopsy approaches that analyze circulating tumor DNA in blood samples. Founded in 2014, Burning Rock primarily serves hospitals, physicians, pharmaceutical companies and research institutions in China. The company has also pursued international research and commercial activities, including collaborations related to oncology drug development and clinical testing. Burning Rock was founded by and is led by Dr. Han Yusheng, who serves as its chief executive officer.AI Generated. May Contain Errors. Read More Burning Rock Biotech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreBNR MarketRank™: 0.16892344818 of 5 starsBurning Rock Biotech scored higher than 3% of companies evaluated by MarketBeat, and ranked 886th out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBurning Rock Biotech has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBurning Rock Biotech has only been the subject of 1 research reports in the past 90 days.Read more about Burning Rock Biotech's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Burning Rock Biotech is -13.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Burning Rock Biotech is -13.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBurning Rock Biotech has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Burning Rock Biotech's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.57% of the float of Burning Rock Biotech has been sold short.Short Interest Ratio / Days to CoverBurning Rock Biotech has a short interest ratio ("days to cover") of 0.99, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Burning Rock Biotech has recently increased by 5.10%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBurning Rock Biotech does not currently pay a dividend.Dividend GrowthBurning Rock Biotech does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Burning Rock Biotech this week, compared to 1 article on an average week. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Burning Rock Biotech insiders have not sold or bought any company stock.Percentage Held by Insiders30.30% of the stock of Burning Rock Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions30.03% of the stock of Burning Rock Biotech is held by institutions.Read more about Burning Rock Biotech's insider trading history. Receive BNR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNR Stock News HeadlinesBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comBurning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years. | Behind the Markets (Ad)Burning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | finanznachrichten.deBurning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | globenewswire.comBurning Rock Biotech Corporate Event Calendar | NASDAQ:BNRJuly 10, 2026 | benzinga.comBurning Rock Announces Founder's Purchase of Its ADSsJuly 2, 2026 | globenewswire.comBurning Rock Reports First Quarter 2026 Financial ResultsJune 9, 2026 | globenewswire.comSee More Headlines BNR Stock Analysis - Frequently Asked Questions How have BNR shares performed this year? Burning Rock Biotech's stock was trading at $20.15 at the beginning of 2026. Since then, BNR stock has decreased by 41.3% and is now trading at $11.82. How were Burning Rock Biotech's earnings last quarter? Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) announced its quarterly earnings data on Thursday, September, 10th. The company reported ($0.20) EPS for the quarter, beating analysts' consensus estimates of ($2.29) by $2.09. The firm earned $19.84 million during the quarter, compared to the consensus estimate of $19.21 million. Burning Rock Biotech had a negative trailing twelve-month return on equity of 12.98% and a negative net margin of 13.60%. When did Burning Rock Biotech's stock split? Shares of Burning Rock Biotech reverse split on the morning of Wednesday, May 15th 2024.The 1-10 reverse split was announced on Wednesday, May 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Burning Rock Biotech IPO? Burning Rock Biotech (BNR) raised $196 million in an initial public offering (IPO) on Friday, June 12th 2020. The company issued 13,500,000 shares at $13.50-$15.50 per share. Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO and CMBI and Tiger Brokers were co-managers. How do I buy shares of Burning Rock Biotech? Shares of BNR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Burning Rock Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Burning Rock Biotech investors own include Brenntag (BNTGF), Advanced Micro Devices (AMD), Salesforce (CRM), Walt Disney (DIS), JPMorgan Chase & Co. (JPM), Merck & Co., Inc. (MRK) and NIO (NIO). Company Calendar Last Earnings9/10/2026Today10/24/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BNR's financial health is in the Green zone, according to TradeSmith. BNR has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BNR CIK1792267 Webwww.brbiotech.com Phone86-185-0164-1666FaxN/AEmployees667Year Founded2014Profitability EPS (Trailing Twelve Months)($0.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.92 million Net Margins-13.60% Pretax Margin-13.48% Return on Equity-12.98% Return on Assets-8.59% Debt Debt-to-Equity RatioN/A Current Ratio3.05 Quick Ratio2.90 Sales & Book Value Annual Sales$77.16 million Price / Sales1.61 Cash FlowN/A Price / Cash FlowN/A Book Value$7.28 per share Price / Book1.62Miscellaneous Outstanding Shares10,520,000Free Float7,331,000Market Cap$124.35 million OptionableNot Optionable Beta1.29 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:BNR) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
